CN1062768C - Medicine for treating rheumatic diseases - Google Patents
Medicine for treating rheumatic diseases Download PDFInfo
- Publication number
- CN1062768C CN1062768C CN98125762A CN98125762A CN1062768C CN 1062768 C CN1062768 C CN 1062768C CN 98125762 A CN98125762 A CN 98125762A CN 98125762 A CN98125762 A CN 98125762A CN 1062768 C CN1062768 C CN 1062768C
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- preparata
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a new medicine for treating rheumatic diseases, which is prepared from the following pure Chinese medicines: stir-frying curare, scorpion, raw ephedra, processed frankincense, processed myrrh, asarum herb, calcined Pyritum, the seed of jog's tears, prepared rhizome of rehmannia, etc., by proportion as raw materials. The pure Chinese medicines are manufactured into medicine powder and encapsulated after pretreatment such as processing, etc. The present invention has the advantages of peculiar formula, obvious therapeutic effect, no toxicity or side effect, no irritation to a gastrointestinal tract, no hormone, no drug abuse, easy administration, general medicinal herb resource, low price and obvious curative effect, and is suitable for popularization.
Description
The present invention relates to a kind of medicine for the treatment of rheumatism, is to be the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically.
Rheumatism is a frequently-occurring disease, commonly encountered diseases, and how touching difficulty is more, and wherein some disease can cause irreversible organic lesion, even maimed disability, and it is seriously endangering people ' s health.And China harm maximum be " rheumatic four diseases ", i.e. rheumatism cold (muscle) arthralgia, rheumatic arthritis, rheumatoid arthritis and ankylosing spondylitis.
Some antirheumatic things that modern medicine had are many can only relief of symptoms, can not stop PD, does not still have a kind of existing good efficacy clinically, safe and reliable again medicine.
The object of the present invention is to provide a kind of rheumatism therapeutic agent that anti-inflammatory and antalgic improves high blood coagulation state that has.
Solution of the present invention is based on motherland's medical science to pathogenetic understanding of rheumatism and Therapeutic Principle, with reference to the modern pharmacological research achievement, from motherland's medicine treasure-house, filter out the natural edible-plant medicine of wind-damp dispelling, removing obstruction in the collateral to relieve pain, dispersing swelling and dissipating binds, blood circulation promoting and blood stasis dispelling, the body resistance strengthening and constitution consolidating.By the theory of Chinese medical science prescription, skim the cream off milk, make its performance anti-inflammatory analgetic, improve collagen fiber, the articular chondrocytes proliferation for repairing promotes body's immunological function, stops, alleviates the effect that development takes place rheumatism.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Semen Strychni (processed) 25-40 part Scorpio 15-25 part Herba Ephedrae 8-15 part
Herba Asari 1-3 part Radix Rehmanniae Preparata 1-3 part Pyritum (calcined) 1-3 part
Bombyx Batryticatus 1-3 part eupolyphage sece steleophaga 1-3 part Fructus Chaenomelis 1-3 part
Radix Glycyrrhizae 1-3 part Olibanum 1-3 part Caulis Spatholobi 1-3 part
Myrrha 1-3 part Radix Paeoniae Alba 1-3 part Semen Coicis 1-3 part
Radix Aconiti Preparata 1-3 part Radix Aconiti Kusnezoffii Preparata 1-3 part Ramulus Cinnamomi 1-3 part
Parasitic 1-3 part
The formula optimization weight proportion scope of preparation medicine of the present invention:
Semen Strychni (processed) 26-35 part Scorpio 16-23 part Herba Ephedrae 0-13 part
Herba Asari 1-2.8 part Radix Rehmanniae Preparata 1-2.8 part Pyritum (calcined) 1-2.8 part
Bombyx Batryticatus 1-2.8 part eupolyphage sece steleophaga 1-2.8 part Fructus Chaenomelis 1-2.8 part
Radix Glycyrrhizae 1-2.8 part Olibanum 1-2.8 part Caulis Spatholobi 1-2.8 part
Myrrha 1-2.8 part Radix Paeoniae Alba 1-2.8 part Semen Coicis 1-2.8 part
Radix Aconiti Preparata 1-2.8 part Radix Aconiti Kusnezoffii Preparata 1-2.8 part Ramulus Cinnamomi 1-2.8 part
Parasitic 1-2.8 part
The optimum weight proportioning of medicine of the present invention is:
10 parts of 20 parts of Herba Ephedrae of 30 portions of Scorpios of Semen Strychni (processed)
2.5 parts of 2.5 parts of Pyritum (calcined)s of 2.5 parts of Radix Rehmanniaes Preparata of Herba Asari
2.5 parts of 2.5 portions of Fructus Chaenomeliss of 2.5 parts of eupolyphage sece steleophagas of Bombyx Batryticatus
2.5 parts of 2.5 portions of Caulis Spatholobis of 2.5 parts of Olibanums of Radix Glycyrrhizae
2.5 parts of 2.5 portions of Semen Coiciss of 2.5 portions of Radix Paeoniae Albas of Myrrha
2.5 parts of 2.5 parts of Ramulus Cinnamomi of 2.5 parts of Radix Aconiti Kusnezoffii Preparatas of Radix Aconiti Preparata
Parasitic 2.5 parts
Above-mentioned each component is made medicine production method of the present invention:
1, gets above crude drug rinsing, oven dry;
2, be crushed to 120 order fine powders and become powder, the capsule of packing into No. 1 stirs.
Clinical drug of the present invention uses the result to show:
1, to select the natural edible-plant medicine for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation.Utilize the comprehensive function treatment wind class disease of the Chinese medicine of respectively distinguishing the flavor of, do not contain hormone, nontoxic to human body, have no side effect.
2, the present invention need not decoct, and does not have as if puckery sense taking convenience.
3, no matter weight all can use separately disease.
For showing the therapeutic effect of medicine of the present invention to rheumatism, the present invention is through the clinical observation of 110 routine systems, and selection medical history, the state of an illness, age, sex and suitable rheumatism patient 110 examples of former Therapeutic Method are matched group.From being in hospital and outpatient service selection case the diagnostic criteria of pressing the rheumatism of ZOHO formulation, the adult rheumatism patient who makes a definite diagnosis, on dietetic therapy and Drug therapy basis, the ESR person of increasing is the object of observation, wherein male 69 examples, women 41 examples, age 27-60 year, course of disease February-20 year.Test group: on former treatment basis, the antirheumatic medicine of stopping using is obeyed medicine of the present invention.Matched group: by normal husband's rheumatism treatment, wherein usage and consumption and test group are complementary.Adopt same procedure to make regular check on ESR.Observed three months, one month is a course of treatment, totally three courses of treatment.
Instructions of taking: 4 balls once, day clothes three times, one after each meal.Clinical test results such as table 1,2.Table 1:
Taking medicine subjective symptoms of the present invention and sign changes
Table 2:
| Group | The example number | Pain | Swelling | Limitation of activity | |||
| Before | After | Before | After | Before | After | ||
| Test group | 110 | 108 | 42 | 96 | 33 | 86 | 33 |
| Matched group | 100 | 96 | 69 | 87 | 60 | 73 | 40 |
| X 2 | 9.58 | 10.9 | 3.75 | ||||
| P | ＜0.05 | ＜0.05 | ＜0.05 | ||||
Erythrocyte sedimentation rate (ESR) relatively before and after the treatment
| The ESR situation of turning out cloudy | The ESR positive | The ESR feminine gender | Significance is checked |
| Before the treatment | 69 | 32 | X 2=15.8 |
| After the treatment | 32 | 65 | P＜0.05 |
As can be seen from Table 1, each symptom and sign are similar substantially before two groups of tests, P＜0.05.After test group was taken medicine of the present invention, card shape and sign improvement were better than matched group P＜0.05.
Table 2 data show that erythrocyte sedimentation rate (ESR) has significance to change before and after the test group treatment, P＜0.05, and promptly test group is taken rheumatism purpose of the present invention.
Test statistics shows: being used for the invention medicine does therapeutic test to 110 rheumatism patients, and that obtains significant curative effect accounts for 52%, substantially effectively accounts for 45%, and invalid accounts for 3%; Total effective rate reaches 97%.
Embodiment takes by weighing raw material by following proportioning:
Semen Strychni (processed) 3000 gram Scorpios 2000 gram Herba Ephedrae 1000 grams
Herba Asari 187.5 gram Radix Rehmanniaes Preparata 187.5 gram Pyritum (calcined)s 187.5 grams
Bombyx Batryticatus 187.5 gram eupolyphage sece steleophagas 187.5 gram Fructus Chaenomeliss 187.5 grams
Radix Glycyrrhizae 187.5 gram Olibanums 187.5 gram Caulis Spatholobis 187.5 grams
The Myrrha 187.5 gram Radix Paeoniae Albas 187.5 gram Semen Coiciss 187.5 grams
Radix Aconiti Preparata 187.5 is restrained Radix Aconiti Kusnezoffii 187.5 gram Ramulus Cinnamomi 187.5 grams
Parasitic 187.5 grams
Get above crude drug rinsing, oven dry is crushed to 120 order fine powders, and the capsule of packing into No. 1 stirs.
Claims (5)
1, the medicine of treatment rheumatism is characterized in that it is by the following weight proportion raw material medicament of preparation side preparation routinely.
Semen Strychni (processed) 25-40 part Scorpio 15-25 part Herba Ephedrae 8-15 part
Herba Asari 1-3 part Radix Rehmanniae Preparata 1-3 part Pyritum (calcined) 1-3 part
Bombyx Batryticatus 1-3 part eupolyphage sece steleophaga 1-3 part Fructus Chaenomelis 1-3 part
Radix Glycyrrhizae 1-3 part Olibanum 1-3 part Caulis Spatholobi 1-3 part
Myrrha 1-3 part Radix Paeoniae Alba 1-3 part Semen Coicis 1-3 part
Radix Aconiti Preparata 1-3 part Radix Aconiti Kusnezoffii Preparata 1-3 part Ramulus Cinnamomi 1-3 part
Parasitic 1-3 part
2, the medicine of treatment rheumatism according to claim 1, wherein the weight proportion of each raw material is:
Semen Strychni (processed) 26-35 part Scorpio 16-23 part Herba Ephedrae 10-13 part
Herba Asari 1-2.8 part Radix Rehmanniae Preparata 1-2.8 part Pyritum (calcined) 1-2.8 part
Bombyx Batryticatus 1-2.8 part eupolyphage sece steleophaga 1-2.8 part Fructus Chaenomelis 1-2.8 part
Radix Glycyrrhizae 1-2.8 part Olibanum 1-2.8 part Caulis Spatholobi 1-2.8 part
Myrrha 1-2.8 part Radix Paeoniae Alba 1-2.8 part Semen Coicis 1-2.8 part
Radix Aconiti Preparata 1-2.8 part Radix Aconiti Kusnezoffii Preparata 1-2.8 part Ramulus Cinnamomi 1-2.8 part
Parasitic 1-2.8 part
3, the medicine of treatment rheumatism according to claim 1, wherein the weight proportion of raw material is:
10 parts of 20 parts of Herba Ephedrae of 30 portions of Scorpios of Semen Strychni (processed)
2.5 parts of 2.5 parts of Pyritum (calcined)s of 2.5 parts of Radix Rehmanniaes Preparata of Herba Asari
2.5 parts of 2.5 portions of Fructus Chaenomeliss of 2.5 parts of eupolyphage sece steleophagas of Bombyx Batryticatus
2.5 parts of 2.5 portions of Caulis Spatholobis of 2.5 parts of Olibanums of Radix Glycyrrhizae
2.5 parts of 2.5 portions of Semen Coiciss of 2.5 portions of Radix Paeoniae Albas of Myrrha
2.5 parts of 2.5 parts of Ramulus Cinnamomi of 2.5 parts of Radix Aconiti Kusnezoffii Preparatas of Radix Aconiti Preparata
Parasitic 2.5 parts
4,, it is characterized in that described medicament is a said dosage form on any pharmaceutics according to the medicine of claim 1,2 or 3 described treatment rheumatisms.
5, the medicine of treatment rheumatism according to claim 4 is characterized in that described medicament is a capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98125762A CN1062768C (en) | 1998-12-18 | 1998-12-18 | Medicine for treating rheumatic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98125762A CN1062768C (en) | 1998-12-18 | 1998-12-18 | Medicine for treating rheumatic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1243734A CN1243734A (en) | 2000-02-09 |
| CN1062768C true CN1062768C (en) | 2001-03-07 |
Family
ID=5229342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98125762A Expired - Fee Related CN1062768C (en) | 1998-12-18 | 1998-12-18 | Medicine for treating rheumatic diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062768C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107970422A (en) * | 2018-01-29 | 2018-05-01 | 寿县永安中医专科医院 | A kind of rheumatism ball and its production technology |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1106256A (en) * | 1994-02-02 | 1995-08-09 | 泰州市唐仁保健用品厂 | Health medicinal bag for stopping numbness and pain and its prodn. method |
| CN1136955A (en) * | 1996-03-05 | 1996-12-04 | 张乃铉 | Multipurpose body-building medicine bag and its preparing process |
-
1998
- 1998-12-18 CN CN98125762A patent/CN1062768C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1106256A (en) * | 1994-02-02 | 1995-08-09 | 泰州市唐仁保健用品厂 | Health medicinal bag for stopping numbness and pain and its prodn. method |
| CN1136955A (en) * | 1996-03-05 | 1996-12-04 | 张乃铉 | Multipurpose body-building medicine bag and its preparing process |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1243734A (en) | 2000-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100548354C (en) | A kind of oral liquid for the treatment of nephropathy | |
| CN1262951A (en) | Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method | |
| CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1062768C (en) | Medicine for treating rheumatic diseases | |
| CN1695682A (en) | External use preparation for treating rheumatisma and bone injuries | |
| CN101045152A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling | |
| CN109045237A (en) | A kind of anaesthetic for treating osteoporosis and rheumatism | |
| CN102258696B (en) | Compound traditional Chinese medicine for treating undifferentiated spondyloarthropathy (uSpA) and application thereof | |
| CN1140086A (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN114652674A (en) | Blood circulation promoting and pain relieving ointment and preparation method thereof | |
| CN1179959A (en) | Chinese patent drug | |
| CN1181879C (en) | Analgestic plaster | |
| CN1879722A (en) | A medicine for treating rheumatic arthritis | |
| CN1088370C (en) | Tongguanshugan ointment and preparation process thereof | |
| CN103349767B (en) | Inula nervosa Wall oil capsule preparation and preparation method thereof | |
| CN1255155C (en) | Medicine for curing rheumatic and rheumatoid diseases and its preparing method | |
| CN101049491A (en) | Application of stomachic pill with cyperus and amomum | |
| CN1279953C (en) | Mediciation for curing female disease | |
| CN1091382C (en) | Compound Lingxian headache-treating capsule and its preparation | |
| CN102743652B (en) | Chinese medicinal preparation for treating male infertility | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1343517A (en) | Medicine for treating dermatopathy and its preparing process | |
| CN102178758A (en) | Medicament for treating peripheral nerve of diabetes | |
| CN1255130C (en) | Chinese traditional medicine for treating pruritus | |
| CN1058177C (en) | Traditional Chinese medicine plaster for treatment of mastosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |